Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck Makes a Bold Move That Could Transform Its Business
09:15am, Thursday, 27'th Apr 2023
Merck is looking to buy clinical stage biotech Prometheus Biosciences for $10.8 billion. The deal could bolster Merck's immunology portfolio with a potential blockbuster of an asset.
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
09:08am, Thursday, 27'th Apr 2023
Merck (MRK) came out with quarterly earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $2.14 per share a year ago.
Merck stock pops premarket after Q1 earnings beat
06:44am, Thursday, 27'th Apr 2023
Merck & Co. Inc.'s stock MRK, -2.66% rose 2% premarket Thursday, after the company posted better-than-expected first-quarter earnings and offered guidance that topped estimates. Rahway, N.J.
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
06:33am, Thursday, 27'th Apr 2023
Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations.
Will Merck's Earnings Beat Give The Pharma Stock A Sorely Needed Boost?
06:30am, Thursday, 27'th Apr 2023
Merck topped first-quarter forecasts Thursday thanks to Keytruda and Gardasil. The results could give Merck stock a much-needed boost.
Markets Continue Steady Slide; META, EBAY Beat Q1 Earnings
07:46pm, Wednesday, 26'th Apr 2023
Except the Nasdaq, which snapped a two-day losing streak and was the only major index in the green all day.
The 7 Best Stocks From Schwab's Dividend ETF
11:43am, Wednesday, 26'th Apr 2023
The Schwab US Divided Equity ETF (NYSEARCA: SCHD ) offers a basket of the best dividend stocks for investors. It's also a standout among top ETFs, having run from $25.50 in 2011 to a peak of $80 last
Drug/Biotech Stocks' Q1 Earnings Due Apr 27: LLY, ABBV & More
10:40am, Wednesday, 26'th Apr 2023
Let's look at the five biotech/pharma companies slated to release quarterly results on Apr 27.
Earnings Beat In The Cards For Merck Stock?
07:15am, Wednesday, 26'th Apr 2023
We expect MRK stock to trade higher, with its revenue and earnings expected to be above the street estimates.
3 Pharma Stocks That Could See a Surge in Demand in 2023
03:55pm, Monday, 24'th Apr 2023
As 2023 unfolds, the pharmaceutical space is blossoming with new opportunities, sparking curiosity for those looking to buy some pharma stocks. With the iShares Biotechnology ETF (NASDAQ: IBB ) ticki
Sell the News? 5 Reasons Tech May Pullback
02:28pm, Monday, 24'th Apr 2023
Though the medium-term trend remains intact for tech, some subtle signs of weakness are appearing beneath the surface. Andrew Rocco breaks it down.
Stocks This Week: Buy Merck
12:00pm, Sunday, 23'rd Apr 2023
Merck is a strong large-cap buy.
Final Trades: MRK, MCD, XOM & GOOGL
06:14pm, Friday, 21'st Apr 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
10:41am, Friday, 21'st Apr 2023
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Merck Is Buying Prometheus Biosciences For About $10.8 Billion
01:13pm, Wednesday, 19'th Apr 2023
Merck (known as MSD outside the United States and Canada) and Prometheus Biosciences recently announced that the companies have entered into a definitive agreement under which Merck, through a subsidi
